Impact of Myo B <i>Basti</i> on Type 2 Diabetes Mellitus Patients with Low Body Mass Index

Rohit Sane; Rahul Mandole; Gurudatta Amin; Harshita Gupta

doi:doi:10.11648/j.ijde.20230801.13

| Peer-Reviewed

Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index

Rohit Sane, Rahul Mandole, Gurudatta Amin, Harshita Gupta

Published in International Journal of Diabetes and Endocrinology (Volume 8, Issue 1)

Received: 24 January 2023 Accepted: 21 February 2023 Published: 3 March 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Type 2 Diabetes Mellitus (T2DM) is a syndrome characterized by a dysregulated metabolism and genetic immune-mediated involvement, and it progressively gets worse with the appearance of life-threatening complications and pathological changes that cause cardiac issues. A negative calorie balance with a low-carb diet is a very effective tool to manage T2DMwith a reduction in orally administered antihyperglycemic agents (OHA) support. As per the twin cycle hypothesis, negative calorie balance can reduce insulin resistance by the reduction in excess adipose tissue but in normal to low BMI T2DM, weight reduction is not advisable. So, the concept of a low-carb and low-calorie diet for good glycemic control is difficult to apply. This study aimed to evaluate impact of 240 ml of Sneha Basti (Myo B Basti: per rectal oil-based herbal formulation) along with an 800 cal/day (Prameh) diet to achieve good glycemic control in T2DM patients with low body mass index. The Myo B Basti shows a mean change of HbA1c in one month from 9.44 to 8.15mmol/mol. Myo B Basti was found to significantly improve HbA1c, BMI, body weight, abdominal girth, SBP, and DBP at the end of the study period i.e., 30th day. Allopathic dependency was also reduced to a great extent. Despite of an 800cal/day diet no major weight loss was observed. Thus, it can be concluded that Myo B Basti can be used as an efficient and safe therapeutic alternative for the treatment of T2DM.

Published in	International Journal of Diabetes and Endocrinology (Volume 8, Issue 1)
DOI	10.11648/j.ijde.20230801.13
Page(s)	12-15
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Type 2 Diabetes Mellitus, Myo B Basti, Prameh Diet

References

[1]	Ramachandran A, Ramachandran S, Snehalatha C, Augustine C, Murugesan N, Viswanathan V, et al. Increasing expenditure on health care incurred by diabetic subjects in a developing country: A study from India. Diabetes Care 2007; 30: 252-6.
[2]	Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI. Mortality in diabetes mellitus - data from a developing region of the world. Diabetes Res ClinPract 1999; 43: 67-74.
[3]	Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003; 26: 1380-4.
[4]	Verma M, Paneri S, Badi P, et al. Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity. Indian Journal of Clinical Biochemistry, 2006, 21 (1): 142-146.
[5]	Tripathi K, Srivastava A. Diabetes mellitus: Complications and therapeutics. Med SciMonit, 2006; 12 (7): RA130-147.
[6]	Matthaei S, Bierwirth R, Fritsche A, et al. Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus. ExpClinEndocrinol Diabetes 2009; 117: 522 – 557.
[7]	Meneses M, Silva B, Sousa M, et al. Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism. Current Pharmaceutical Design. 2015; 21 (25): 3606-3620.
[8]	Egede L, Axon R, Gebregziabher M, et al. Medication Nonadherence in Diabetes. Diabetes Care. 2012; 35: 2533– 2539.
[9]	Nair D. Understanding the Role of Ayurveda Panchakarma Therapy W. S. R. to Vasthi (Enema) in the Management of Type II Diabetes Mellitus- A Case Review. Int J Complement Alt Med. 2017; 8 (6): 00276.
[10]	Giri S, Patnaik S, Kumar K, et al. Potential of ayurvedicpanchakarma in prevention and management of lifestyle disorders with special reference to madhumeha, J of Ayurveda and Hol Med (JAHM). 2015; 3 (5): 82-91.
[11]	Kalpana siddhi Adhyaya Charaksamhita. Agnivesha. Ayurveda Dipika English Commentary, Chakrapanidatt, Siddhi Sthana Chaukhamba SanskritSansthanVaranasi1990684.
[12]	Netra Basti Pravibhag Adhyay, (35: 25) SushrutaSamhita, Sushruta, Ayurveda Tatva Sandeepika Hindi Commentary, Ambikadatta Sastri, Chikitsa Sthana Chaukhamba Sanskrit SansthanVaranasi2003155.
[13]	“Clinical importance of Glycosylated hemoglobin (HbA1c) in diabetes mellitus patients”. Retrieved from https://www.researchgate.net/publication/26575867_Clinical_Importance_Of_Glycosylated_Hemoglobin_HbA1c_In_Diabetes_Mellitus_Patients. [Last accessed on march 11th 2018].
[14]	Chaudhury A, Duvoor C, Reddy V, et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front. Endocrinol. 2017; 8 (6): 1-12.
[15]	Perwitasari D, Urbayatun S. Treatment Adherence and Quality of Life in Diabetes Mellitus Patients in Indonesia. Sage Open. 2016: 1-7.

Cite This Article

Plain Text BibTeX RIS

APA Style

Rohit Sane, Rahul Mandole, Gurudatta Amin, Harshita Gupta. (2023). Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index. International Journal of Diabetes and Endocrinology, 8(1), 12-15. https://doi.org/10.11648/j.ijde.20230801.13

Copy | Download

ACS Style

Rohit Sane; Rahul Mandole; Gurudatta Amin; Harshita Gupta. Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index. Int. J. Diabetes Endocrinol. 2023, 8(1), 12-15. doi: 10.11648/j.ijde.20230801.13

Copy | Download

AMA Style

Rohit Sane, Rahul Mandole, Gurudatta Amin, Harshita Gupta. Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index. Int J Diabetes Endocrinol. 2023;8(1):12-15. doi: 10.11648/j.ijde.20230801.13

Copy | Download

@article{10.11648/j.ijde.20230801.13,
  author = {Rohit Sane and Rahul Mandole and Gurudatta Amin and Harshita Gupta},
  title = {Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index},
  journal = {International Journal of Diabetes and Endocrinology},
  volume = {8},
  number = {1},
  pages = {12-15},
  doi = {10.11648/j.ijde.20230801.13},
  url = {https://doi.org/10.11648/j.ijde.20230801.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20230801.13},
  abstract = {Type 2 Diabetes Mellitus (T2DM) is a syndrome characterized by a dysregulated metabolism and genetic immune-mediated involvement, and it progressively gets worse with the appearance of life-threatening complications and pathological changes that cause cardiac issues. A negative calorie balance with a low-carb diet is a very effective tool to manage T2DMwith a reduction in orally administered antihyperglycemic agents (OHA) support. As per the twin cycle hypothesis, negative calorie balance can reduce insulin resistance by the reduction in excess adipose tissue but in normal to low BMI T2DM, weight reduction is not advisable. So, the concept of a low-carb and low-calorie diet for good glycemic control is difficult to apply. This study aimed to evaluate impact of 240 ml of Sneha Basti (Myo B Basti: per rectal oil-based herbal formulation) along with an 800 cal/day (Prameh) diet to achieve good glycemic control in T2DM patients with low body mass index. The Myo B Basti shows a mean change of HbA1c in one month from 9.44 to 8.15mmol/mol. Myo B Basti was found to significantly improve HbA1c, BMI, body weight, abdominal girth, SBP, and DBP at the end of the study period i.e., 30th day. Allopathic dependency was also reduced to a great extent. Despite of an 800cal/day diet no major weight loss was observed. Thus, it can be concluded that Myo B Basti can be used as an efficient and safe therapeutic alternative for the treatment of T2DM.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index
AU  - Rohit Sane
AU  - Rahul Mandole
AU  - Gurudatta Amin
AU  - Harshita Gupta
Y1  - 2023/03/03
PY  - 2023
N1  - https://doi.org/10.11648/j.ijde.20230801.13
DO  - 10.11648/j.ijde.20230801.13
T2  - International Journal of Diabetes and Endocrinology
JF  - International Journal of Diabetes and Endocrinology
JO  - International Journal of Diabetes and Endocrinology
SP  - 12
EP  - 15
PB  - Science Publishing Group
SN  - 2640-1371
UR  - https://doi.org/10.11648/j.ijde.20230801.13
AB  - Type 2 Diabetes Mellitus (T2DM) is a syndrome characterized by a dysregulated metabolism and genetic immune-mediated involvement, and it progressively gets worse with the appearance of life-threatening complications and pathological changes that cause cardiac issues. A negative calorie balance with a low-carb diet is a very effective tool to manage T2DMwith a reduction in orally administered antihyperglycemic agents (OHA) support. As per the twin cycle hypothesis, negative calorie balance can reduce insulin resistance by the reduction in excess adipose tissue but in normal to low BMI T2DM, weight reduction is not advisable. So, the concept of a low-carb and low-calorie diet for good glycemic control is difficult to apply. This study aimed to evaluate impact of 240 ml of Sneha Basti (Myo B Basti: per rectal oil-based herbal formulation) along with an 800 cal/day (Prameh) diet to achieve good glycemic control in T2DM patients with low body mass index. The Myo B Basti shows a mean change of HbA1c in one month from 9.44 to 8.15mmol/mol. Myo B Basti was found to significantly improve HbA1c, BMI, body weight, abdominal girth, SBP, and DBP at the end of the study period i.e., 30th day. Allopathic dependency was also reduced to a great extent. Despite of an 800cal/day diet no major weight loss was observed. Thus, it can be concluded that Myo B Basti can be used as an efficient and safe therapeutic alternative for the treatment of T2DM.
VL  - 8
IS  - 1
ER  -

Copy | Download

Author Information

Rohit Sane

Department of Research and Development, Madhavbaug Cardiac Clinic and Hospital, Thane, India
Rahul Mandole

Department of Research and Development, Madhavbaug Cardiac Clinic and Hospital, Thane, India
Gurudatta Amin

Department of Medical Operations, Madhavbaug Cardiac Clinic and Hospital, Thane, India
Harshita Gupta

Department of Research and Development, Madhavbaug Cardiac Clinic and Hospital, Thane, India

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Rohit Sane, Rahul Mandole, Gurudatta Amin, Harshita Gupta. (2023). Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index. International Journal of Diabetes and Endocrinology, 8(1), 12-15. https://doi.org/10.11648/j.ijde.20230801.13

Copy | Download

ACS Style

Rohit Sane; Rahul Mandole; Gurudatta Amin; Harshita Gupta. Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index. Int. J. Diabetes Endocrinol. 2023, 8(1), 12-15. doi: 10.11648/j.ijde.20230801.13

Copy | Download

AMA Style

Rohit Sane, Rahul Mandole, Gurudatta Amin, Harshita Gupta. Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index. Int J Diabetes Endocrinol. 2023;8(1):12-15. doi: 10.11648/j.ijde.20230801.13

Copy | Download

@article{10.11648/j.ijde.20230801.13,
  author = {Rohit Sane and Rahul Mandole and Gurudatta Amin and Harshita Gupta},
  title = {Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index},
  journal = {International Journal of Diabetes and Endocrinology},
  volume = {8},
  number = {1},
  pages = {12-15},
  doi = {10.11648/j.ijde.20230801.13},
  url = {https://doi.org/10.11648/j.ijde.20230801.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20230801.13},
  abstract = {Type 2 Diabetes Mellitus (T2DM) is a syndrome characterized by a dysregulated metabolism and genetic immune-mediated involvement, and it progressively gets worse with the appearance of life-threatening complications and pathological changes that cause cardiac issues. A negative calorie balance with a low-carb diet is a very effective tool to manage T2DMwith a reduction in orally administered antihyperglycemic agents (OHA) support. As per the twin cycle hypothesis, negative calorie balance can reduce insulin resistance by the reduction in excess adipose tissue but in normal to low BMI T2DM, weight reduction is not advisable. So, the concept of a low-carb and low-calorie diet for good glycemic control is difficult to apply. This study aimed to evaluate impact of 240 ml of Sneha Basti (Myo B Basti: per rectal oil-based herbal formulation) along with an 800 cal/day (Prameh) diet to achieve good glycemic control in T2DM patients with low body mass index. The Myo B Basti shows a mean change of HbA1c in one month from 9.44 to 8.15mmol/mol. Myo B Basti was found to significantly improve HbA1c, BMI, body weight, abdominal girth, SBP, and DBP at the end of the study period i.e., 30th day. Allopathic dependency was also reduced to a great extent. Despite of an 800cal/day diet no major weight loss was observed. Thus, it can be concluded that Myo B Basti can be used as an efficient and safe therapeutic alternative for the treatment of T2DM.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index
AU  - Rohit Sane
AU  - Rahul Mandole
AU  - Gurudatta Amin
AU  - Harshita Gupta
Y1  - 2023/03/03
PY  - 2023
N1  - https://doi.org/10.11648/j.ijde.20230801.13
DO  - 10.11648/j.ijde.20230801.13
T2  - International Journal of Diabetes and Endocrinology
JF  - International Journal of Diabetes and Endocrinology
JO  - International Journal of Diabetes and Endocrinology
SP  - 12
EP  - 15
PB  - Science Publishing Group
SN  - 2640-1371
UR  - https://doi.org/10.11648/j.ijde.20230801.13
AB  - Type 2 Diabetes Mellitus (T2DM) is a syndrome characterized by a dysregulated metabolism and genetic immune-mediated involvement, and it progressively gets worse with the appearance of life-threatening complications and pathological changes that cause cardiac issues. A negative calorie balance with a low-carb diet is a very effective tool to manage T2DMwith a reduction in orally administered antihyperglycemic agents (OHA) support. As per the twin cycle hypothesis, negative calorie balance can reduce insulin resistance by the reduction in excess adipose tissue but in normal to low BMI T2DM, weight reduction is not advisable. So, the concept of a low-carb and low-calorie diet for good glycemic control is difficult to apply. This study aimed to evaluate impact of 240 ml of Sneha Basti (Myo B Basti: per rectal oil-based herbal formulation) along with an 800 cal/day (Prameh) diet to achieve good glycemic control in T2DM patients with low body mass index. The Myo B Basti shows a mean change of HbA1c in one month from 9.44 to 8.15mmol/mol. Myo B Basti was found to significantly improve HbA1c, BMI, body weight, abdominal girth, SBP, and DBP at the end of the study period i.e., 30th day. Allopathic dependency was also reduced to a great extent. Despite of an 800cal/day diet no major weight loss was observed. Thus, it can be concluded that Myo B Basti can be used as an efficient and safe therapeutic alternative for the treatment of T2DM.
VL  - 8
IS  - 1
ER  -

Copy | Download